FEATURED POST
What You Can Learn from 7 Theme Fusion Success Stories
Nam lacinia arcu tortor, nec luctus nibh dignissim eu. Nulla sit amet maximus nulla. Pellentesque a accumsan eros, ac molestie nulla. Morbi interdum in neque vitae vulputate.
Albanian CROs Unite to Form New Association
On January 24th, a milestone was reached for clinical research in Albania. Three leading CROs came together to sign the statute establishing [...]
CVBF CEO, Donato Bonifazi, Re-elected to AICRO Board, Continuing Commitment to Clinical Research Collaboration
Donato Bonifazi, our CEO, has been elected as a board member at AICRO (Italian Association of Clinical Research Organizations). Donato Bonifazi is [...]
iCAN 2024 Advocacy and Research Summit
We are thrilled to announce that the 2024 iCAN Advocacy and Research Summit will take placefrom July 15-19 in Bari, Italy. As [...]
Quality Assurance Head, Mariagrazia Felisi, Leads Workshop on EU Clinical Trial Regulation
On 27 June 2023, Mariagrazia Felisi, our Quality Assurance Head and Internal Auditor, co-chairing the "AICRO Clinical Trial Center Working [...]
Advanced Therapies: A Researcher’s Perspective on ATMPs – Insights from Giovanni Migliaccio
Giovanni Migliaccio, the Scientific Director of CVBF, recently participated at the MEP Interest Group 2023 Conference organized by the European [...]
EUCROF Paediatric Training: Our CEO’s Vision for Advancing Paediatric Clinical Research
In the ever-advancing world of clinical research, staying at the forefront of knowledge and practices is imperative. On 12 September [...]
Developed tools for Rare Diseases researchers – ERICA & EJP RD Joint Conference
Bonka Georgieva, CVBF's Project Manager, presented at the "ERICA & EJP RD Joint Conference" held in Amsterdam. The event served [...]
Survey: International Clinical Trials Registry Platform (ICTRP) search portal user experience
In order to improve the user experience of the International Clinical Trials Registry Platform (ICTRP) search portal, the World Health Organization (WHO) is seeking input [...]
CVBF spotlight on scientific literature: “Why children have to wait years for new drugs”
This recent article is part of Nature Outlook: Children‘s health and focuses on the lack of medicines approved for paediatric use. According to the article, [...]
First gene therapy to treat haemophilia B
EMA has recommended granting a conditional marketing authorisation in the European Union (EU) for Hemgenix (etranacogene dezaparvovec), the the first gene therapy for the treatment [...]
Event: The next steps for a real European Health Union – Delivering patient care through digital solutions
This in-person event, organized by the European Association of E-Pharmacies (EAEP) will be held on Thursday, 27 October at TownHall Europe (Square de Meeûs 5, [...]
CVBF participates in the Smarter Programme For Technological Innovation
Thanks to the close collaboration with Aldo Moro University of Bari, Exprivia spa and Hero srl, and following the agreement signed with the Ministry of University [...]
CVBF September Special Issue
This new Special Issue is dedicated to the active involvement of CVBF in the European Joint Programme for Rare Diseases (EJP RD), a consortium that [...]